Restructuring and Survival Signals: How 10 Off-the-Radar Stocks Are Navigating the Capital PivotGlobal Report·Jul 8 at 10:32 PMJZ-12.16%UAVS-3.60%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 8 at 12:05 PMCUPR-3.60%TVRD-12.30%
11 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 2 at 12:05 PMLIMN+1.34%ELTX-2.03%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 2 at 07:05 AMLIMN+1.34%XAIR+0.92%
Top Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watchrttnews·Jul 1 at 10:22 PMCANF+1.27%ELTX-2.03%
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering | ELTX Stock NewsStockTitan·Jul 1 at 03:25 PMELTX-2.03%
Elicio Therapeutics Added to Russell 2000® and Russell 3000® IndexesUnusual Whales·Jun 29 at 07:02 AMELTX-2.03%
Elicio Therapeutics posts AMPLIFY-7P presentation on ELI-002 7P in metastatic mKRAS pancreatic cancerPUBT·Jun 25 at 07:06 AMELTX-2.03%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jun 18 at 12:06 PMATPC-1.29%APLM-4.06%
U.S. stock night market volatility: KRAS vaccine phase II failure causes stock price to plummet 73%, further decline of 14% in night tradingPrice Alert·Jun 17 at 07:16 PMELTX-2.03%
U.S. stock night trading opened with fluctuations: Elicio Therapeutics fell 15.92% in night trading; Arm rose 4.35% in night tradingPrice Alert·Jun 17 at 07:11 PMELTX-2.03%ARM-8.11%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jun 17 at 04:06 PMADTX0.00%NRSN-13.99%
Elicio Therapeutics Falls 13% After Hours as Pancreatic Cancer Drug Data Draws FocusUS Stock Market Update·Jun 17 at 04:00 PMELTX-2.03%
